These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 31804717)

  • 1. Effects of disulfide bond and cholesterol derivatives on human calcitonin amyloid formation.
    Lantz R; Busbee B; Wojcikiewicz EP; Du D
    Biopolymers; 2020 May; 111(5):e23343. PubMed ID: 31804717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flavonoids with Vicinal Hydroxyl Groups Inhibit Human Calcitonin Amyloid Formation.
    Lantz R; Busbee B; Wojcikiewicz EP; Du D
    Chemistry; 2020 Oct; 26(57):13063-13071. PubMed ID: 32458489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibiting Human Calcitonin Fibril Formation with Its Most Relevant Aggregation-Resistant Analog.
    Chen YT; Hu KW; Huang BJ; Lai CH; Tu LH
    J Phys Chem B; 2019 Dec; 123(48):10171-10180. PubMed ID: 31692350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study of amyloid fibril formation by residues 15-19 of the human calcitonin hormone: a single beta-sheet model with a small hydrophobic core.
    Haspel N; Zanuy D; Ma B; Wolfson H; Nussinov R
    J Mol Biol; 2005 Feb; 345(5):1213-27. PubMed ID: 15644216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of aromatic residues in amyloid fibril formation of human calcitonin by solid-state 13C NMR and molecular dynamics simulation.
    Itoh-Watanabe H; Kamihira-Ishijima M; Javkhlantugs N; Inoue R; Itoh Y; Endo H; Tuzi S; Saitô H; Ueda K; Naito A
    Phys Chem Chem Phys; 2013 Jun; 15(23):8890-901. PubMed ID: 23552643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth-incompetent monomers of human calcitonin lead to a noncanonical direct relationship between peptide concentration and aggregation lag time.
    Kamgar-Parsi K; Hong L; Naito A; Brooks CL; Ramamoorthy A
    J Biol Chem; 2017 Sep; 292(36):14963-14976. PubMed ID: 28739873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlling the self-assembly of human calcitonin: a theoretical approach using molecular dynamics simulations.
    Paul S; Paul S
    Phys Chem Chem Phys; 2021 Jul; 23(26):14496-14510. PubMed ID: 34184696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Charged Cholesterol Derivatives on Aβ40 Amyloid Formation.
    Elbassal EA; Liu H; Morris C; Wojcikiewicz EP; Du D
    J Phys Chem B; 2016 Jan; 120(1):59-68. PubMed ID: 26652010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural Perturbation of Monomers Determines the Amyloid Aggregation Propensity of Calcitonin Variants.
    Liu Y; Wang Y; Zhang Y; Zou Y; Wei G; Ding F; Sun Y
    J Chem Inf Model; 2023 Jan; 63(1):308-320. PubMed ID: 36456917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrillation of Human Calcitonin and Its Analogs: Effects of Phosphorylation and Disulfide Reduction.
    Renawala HK; Chandrababu KB; Topp EM
    Biophys J; 2021 Jan; 120(1):86-100. PubMed ID: 33220304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tyrosine 12 of human calcitonin modulates its amyloid formation, membrane binding, and bioactivity.
    Hsieh IC; Chen TW; Chuang YP; Lai YJ; Tu LH
    Biochimie; 2022 Jun; 197():121-129. PubMed ID: 35240220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Converting the highly amyloidogenic human calcitonin into a powerful fibril inhibitor by three-dimensional structure homology with a non-amyloidogenic analogue.
    Andreotti G; Vitale RM; Avidan-Shpalter C; Amodeo P; Gazit E; Motta A
    J Biol Chem; 2011 Jan; 286(4):2707-18. PubMed ID: 21078667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the spherical intermediates and fibril formation of hCT in HEPES solution using solid-state 13C-NMR and transmission electron microscopy.
    Itoh-Watanabe H; Kamihira-Ishijima M; Kawamura I; Kondoh M; Nakakoshi M; Sato M; Naito A
    Phys Chem Chem Phys; 2013 Oct; 15(39):16956-64. PubMed ID: 24002168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cu/Zn Superoxide Dismutase Forms Amyloid Fibrils under Near-Physiological Quiescent Conditions: The Roles of Disulfide Bonds and Effects of Denaturant.
    Khan MAI; Respondek M; Kjellström S; Deep S; Linse S; Akke M
    ACS Chem Neurosci; 2017 Sep; 8(9):2019-2026. PubMed ID: 28585802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid-induced calcitonin fibrillation blocks membrane interactions of a peptide antibiotic.
    Sheynis T; Jelinek R
    J Phys Chem B; 2010 Dec; 114(47):15530-5. PubMed ID: 21053950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of sodium tetrathionate on amyloid fibril: Insight into the role of disulfide bond in amyloid progression.
    Sarkar N; Kumar M; Dubey VK
    Biochimie; 2011 May; 93(5):962-8. PubMed ID: 21354256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Kinetics of Amyloid Fibril Formation by
    Balobanov V; Chertkova R; Egorova A; Dolgikh D; Bychkova V; Kirpichnikov M
    Biomolecules; 2020 Feb; 10(2):. PubMed ID: 32033353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A dimer model of human calcitonin13-32 forms an α-helical structure and robustly aggregates in 50% aqueous 2,2,2-trifluoroethanol solution.
    Kawashima H; Katayama M; Yoshida R; Akaji K; Asano A; Doi M
    J Pept Sci; 2016 Jul; 22(7):480-4. PubMed ID: 27238594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloid fibril formation by bovine α1-acid glycoprotein in a reducing environment: The role of disulfide bridges on the observed aggregation kinetics.
    Baldassarre M; Maggiore B; Scirè A; Tanfani F
    Biochimie; 2015 Nov; 118():244-52. PubMed ID: 26409898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of metal ions, disulfide reduction and mutations related to familial ALS promote formation of amyloid-like aggregates from superoxide dismutase.
    Oztug Durer ZA; Cohlberg JA; Dinh P; Padua S; Ehrenclou K; Downes S; Tan JK; Nakano Y; Bowman CJ; Hoskins JL; Kwon C; Mason AZ; Rodriguez JA; Doucette PA; Shaw BF; Valentine JS
    PLoS One; 2009; 4(3):e5004. PubMed ID: 19325915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.